Technology

Idera Pharmaceuticals

$5.98
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (+0.50%) Today
$0.00 (0.00%) As of 12:18 PM UTC after-hours

Why Robinhood?

You can buy or sell IDRA and other stocks, options, and ETFs commission-free!

About IDRA

Idera Pharmaceuticals, Inc. Common Stock, also called Idera Pharmaceuticals, is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Cambridge, MA. The listed name for IDRA is Idera Pharmaceuticals, Inc. Common Stock.

CEO
Vincent J. Milano
Employees
36
Headquarters
Exton, Pennsylvania
Founded
1989
Market Cap
221.89M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
557.13K
High Today
$6.10
Low Today
$5.70
Open Price
$6.00
Volume
534.14K
52 Week High
$6.14
52 Week Low
$0.813

Collections

IDRA Earnings

-$0.46
-$0.23
-$0.01
$0.22
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 10, After Hours

You May Also Like

NEPT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure